KIFC2

Chr 8

kinesin family member C2

KIFC2 encodes a kinesin motor protein that hydrolyzes ATP to drive microtubule-based transport of synaptic vesicles and neurotransmitter receptor complexes in neurons. Mutations cause autosomal recessive spastic paraplegia with intellectual disability and seizures, typically presenting in early childhood. The gene shows minimal constraint against loss-of-function variants based on population data.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
57
P/LP submissions
0%
P/LP missense
0.83
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryKIFC2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
56 unique Pathogenic / Likely Pathogenic· 204 VUS of 303 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.83LOEUF
pLI 0.000
Z-score 2.41
OE 0.59 (0.430.83)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-1.41Z-score
OE missense 1.19 (1.101.27)
540 obs / 455.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.59 (0.430.83)
00.351.4
Missense OE1.19 (1.101.27)
00.61.4
Synonymous OE1.65
01.21.6
LoF obs/exp: 24 / 40.6Missense obs/exp: 540 / 455.5Syn Z: -7.23
DN
0.79top 25%
GOF
0.78top 25%
LOF
0.3163th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

303 submitted variants in ClinVar

Classification Summary

Pathogenic51
Likely Pathogenic5
VUS204
Likely Benign21
Benign6
51
Pathogenic
5
Likely Pathogenic
204
VUS
21
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
51
0
51
Likely Pathogenic
0
0
5
0
5
VUS
2
173
29
0
204
Likely Benign
0
12
2
7
21
Benign
0
0
5
1
6
Total2185928287

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KIFC2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC